Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma.
Glazer ES, Piccirillo M, Albino V, Di Giacomo R, Palaia R, Mastro AA, Beneduce G, Castello G, De Rosa V, Petrillo A, Ascierto PA, Curley SA, Izzo F.
Glazer ES, et al. Among authors: izzo f.
J Clin Oncol. 2010 May 1;28(13):2220-6. doi: 10.1200/JCO.2009.26.7765. Epub 2010 Mar 29.
J Clin Oncol. 2010.
PMID: 20351325
Clinical Trial.